SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001513160-14-000083
Filing Date
2014-12-17
Accepted
2014-12-17 16:52:02
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 OXIS INTERNATIONAL QUARTERLY REPORT oxis10q093013.htm 10-Q 545630
2 CERTIFICATION SECTION 302 ex311.htm EX-31.1 12263
3 CERTIFICATION SECTION 302 ex312.htm EX-31.2 12208
4 CERTIFICATION SECTION 906 ex321.htm EX-32.1 5948
5 CERTIFICATION SECTION 906 ex322.htm EX-32.2 6005
  Complete submission text file 0001513160-14-000083.txt   2753783

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oxis-20130930.xml EX-101.INS 321523
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT oxis-20130930.xsd EX-101.SCH 20137
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxis-20130930_cal.xml EX-101.CAL 35580
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxis-20130930_def.xml EX-101.DEF 43522
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxis-20130930_lab.xml EX-101.LAB 157972
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxis-20130930_pre.xml EX-101.PRE 117268
Mailing Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210
Business Address 468 N. CAMDEN DR. 2ND FLOOR BEVERLY HILLS CA 90210 (310) 551-4020
OXIS INTERNATIONAL INC (Filer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-08092 | Film No.: 141293110
SIC: 2834 Pharmaceutical Preparations